Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-029918
Filing Date
2024-12-19
Accepted
2024-12-19 18:49:42
Documents
1
Period of Report
2024-12-17

Document Format Files

Seq Description Document Type Size
1 form4-12192024_111239.html 4  
1 form4-12192024_111239.xml 4 6047
  Complete submission text file 0001415889-24-029918.txt   7494
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VENTYX BIOSCINECES, INC. 332 ENCINITAS BLVD., SUITE 200 ENCINITAS CA 92024
Business Address
Mohan Raju (Reporting) CIK: 0001878125 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 241564665